SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news

 

 

High astaxanthin intakes questioned in the EU

1 comment

By Shane Starling+

23-Jul-2014
Last updated on 28-Jul-2014 at 17:51 GMT2014-07-28T17:51:35Z

AstaReal astaxanthin vats
AstaReal astaxanthin vats

The European Union chief science agency has failed to back astaxanthin consumption at levels over 4 mg astaxanthin per day after responding to a novel foods application from Japanese player, Fuji Chemical-owned AstaReal.

The application sought to use the algae-sourced carotenoid in various forms in, fermented liquid dairy products, non-fermented liquid dairy products, fermented soya products and fruit drinks for healthy adults.

It proposed a level of 1.6 mg astaxanthin per 100 g or 100 mL of food or drink.

In the European Union the market is challenged due to the lack of novel foods approval and rejected health claims from the European Food Safety Authority (EFSA).

Research has linked astaxanthin with skin and eye health, immune function, healthy tendons, anti-aging, energy and heart benefits.

When looking at the current set of data for various forms of AstaReal’s algae-sourced carotenoid, the European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) found issues at the 4 mg level (0.06 mg per kilogram of body weight).

The NDA found there were no toxicity issues with the nutrients in the proposed oil and powder forms. The consumption of the NFIs [novel food ingredients] is not considered to be nutritionally disadvantageous.”

But based on an already established average daily intake (ADI) of 0.034 mg/kg bw it said the daily level of 4 mg (0.06 mg/kg bw), “exceed the ADI by approximately two- and three-fold, respectively.”

Not established...

This was based on use levels in the proposed food categories (0.106 mg/kg bw per day).

“The Panel therefore concludes that the safety of the NFIs AstaREAL A1010 and AstaREAL L10 at the proposed use and use levels has not been established.”

“In the European diet, astaxanthin is primarily consumed through seafood, with wild and farmed salmonids as a major source,” the NDA noted.

“Considering the additional intake from salmon and trout consumption, total mean and high daily intakes of astaxanthin of 0.125 mg/kg bw and 0.286 mg/kg bw were calculated.”

Bioavailability was affected by, “its form, its mode of consumption and the smoking habits of the consumer.”

AstaReal said it was preparing a reaction to the opinion.

1 comment (Comments are now closed)

Missing text?

Is there text missing in this paragraph:
When looking at the current set of data the European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) the application for various forms of AstaReal’s algae-sourced carotenoid, the panel found at the 4 mg level (0.06 mg per kilogram of body weight)...

Report abuse

Posted by Michael Goehner
24 July 2014 | 14h262014-07-24T14:26:59Z

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars